Results for shape of product translation from Danish to Italian

type of product
tip ta' prodott

summary of product characteristics (spc)
summary of product characteristics (spc)

i- beamthe shape of the cursor
barra verticalethe shape of the cursor

Ændr markørens formthe shape of the cursor
cambia la forma del cursorethe shape of the cursor

blokthe shape of the cursor, similar to a capital i
bloccothe shape of the cursor, similar to a capital i

titel på dokumentet antimicrobials for veterinary use summary of product characteristics for antimicrobial products ectoparasiticide guidance for sheep, cattle and goats fluid therapy
titolo del documento antimicrobials for veterinary use summary of product characteristics for antimicrobial products ectoparasiticide guidance for sheep, cattle and goats fluid therapy

titel på dokumentet antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
titolo del documento antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy

prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)
prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)

grundlag af den forelagte dokumentation, den faglige drøftelse i udvalget og den foreslåede ordlyd i den ajourførte udgave af guideline on summary of product characteristics fra oktober 2005 og den seneste qrd- model,
proposti dal richiedente sono stati valutati in base alla documentazione presentata, alla discussione scientifica avvenuta in seno al comitato e alla nuova formulazione proposta nelle linee guida aggiornate sul riassunto delle caratteristiche del prodotto, dell’ ottobre 2005, nonché nell’ ultima versione del modello di revisione qualitativa dei documenti (qrd),

the expiry date of products incorporating plasma- derived products as stabilisers or excipients:
the expiry date of products incorporating plasma-derived products as stabilisers or excipients:

grundlag af den forelagte dokumentation, den faglige drøftelse i udvalget og den foreslåede ordlyd i den ajourførte udgave af guideline on summary of product characteristics fra oktober 2005 og de seneste qrd- modeller (version 7),
proposti dal richiedente sono stati valutati in base alla documentazione presentata, alla discussione scientifica avvenuta in seno al comitato e alla nuova formulazione proposta nell’ ottobre 2005 nelle linee guida aggiornate sul riassunto delle caratteristiche del prodotto nonché all’ ultima versione 7 dei modelli di revisione qualitativa dei documenti (qrd)

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)